Inducen-Res

Bacillus anthracis, Bordetella holmesii, Bordetella pertussis, Burkholderia cepacian +Lipopolysaccharide/endotoxin, Burkholderia pseudomallei +Endotoxin/Lipopolysaccharides, Chlamydophila pneumoniae, Corynebacter tuberculostericum, Enterobacter hormaechei, Francisella tularensis + Lipopolysaccharide/Endotoxin, Haemophilus influenzae, Mycoplasma pneumoniae, Mycoplasma hominis, (Chlamydia pneumoniae), Legionella pneumophila, Mycobacteria Avium complex, Mycobacterium abcessus, Mycobacterium kansasii, Mycobacterium intracellularis, Mycobacterium tuberculosis, Mycobacterium tuberculosis (drug-resistant), Prevotella intermedia, Prevotella melaninogenica, Pseudomonas aeruginosa, Pseudomonas fluorescens, Serratia marcescens, Staph albus, Staphylococcus aureus, Tannerella forsythia, Tannerella forsythia

Sinusitis • Upper Airway • Bronchitis • Pneumonia • Chronic Lung Disease

Symptom Timing

• Improves then worsens after viral URI (day 5–10) → Haemophilus influenzae, Staphylococcus aureus
• Persistent cough >3 weeks, minimal fever → Mycoplasma pneumoniae, Chlamydia pneumoniae, Bordetella pertussis
• Slow, progressive symptoms over months → NTM (MAC, M. abscessus, M. kansasii), Mycobacterium tuberculosis

Fever & Systemic Toxicity

• High fever, confusion, hyponatremia → Legionella pneumophila
• Severe pneumonia with hemoptysis, weight loss → Mycobacterium tuberculosis
• Rapid deterioration post-influenza → Staphylococcus aureus

Host & Exposure Clues

• COPD / smoker → H. influenzae, Pseudomonas aeruginosa
• Bronchiectasis / CF → Pseudomonas, Burkholderia cepacia complex, NTM
• Hospitalized / devices / irrigations → Pseudomonas, Serratia, Enterobacter
• Dental disease / aspiration risk → Prevotella spp.
• Water exposure (hotels, HVAC, showers) → Legionella
• Animal / soil exposure (regional) → Francisella tularensis, Burkholderia pseudomallei

Diagnostic Pattern Clues

• Negative routine cultures, PCR positive → Mycoplasma, Chlamydia, Bordetella
• AFB positive, slow growth → TB or NTM
• Biofilm behavior / antibiotic failure → S. aureus, Pseudomonas

Tier 1 — Primary Sinus Pathogens

• Haemophilus influenzae Most common bacterial sinusitis cause; post-viral “double worsening”
• Staphylococcus aureus Key driver of chronic rhinosinusitis (CRS); biofilm-mediated persistence
• Prevotella melaninogenica
• Prevotella intermedia Anaerobic inflammation; odontogenic and chronic sinus disease
• Corynebacterium tuberculostearicum CRS-associated dysbiosis marker; pathogenic in select hosts

Tier 2 — Contributory / Context-Dependent

• Mycoplasma pneumoniae – pharyngitis → bronchitis overlap
• Chlamydia pneumoniae – prolonged URI with inflammation
• Bordetella pertussis – early URI mimic, later cough dominance
• Pseudomonas aeruginosa – post-surgical or immunocompromised CRS

Tier 3 — Rare / Secondary Sinus Involvement

• Legionella pneumophila
• Mycobacterium tuberculosis
• NTM (MAC, M. abscessus, M. kansasii)
• Serratia marcescens
• Enterobacter hormaechei
• Francisella tularensis
• Burkholderia pseudomallei
• Bacillus anthracis

Tier 1 — Major LRT Pathogens

• Haemophilus influenzae (COPD exacerbations, pneumonia)
• Mycoplasma pneumoniae (atypical pneumonia)
• Chlamydia pneumoniae (subacute pneumonia)
• Legionella pneumophila (severe pneumonia)
• Staphylococcus aureus (post-viral, necrotizing pneumonia)
• Pseudomonas aeruginosa (bronchiectasis, ICU, CF)
• Mycobacterium tuberculosis (including drug-resistant TB)

Tier 2 — Chronic / Opportunistic

• Mycobacterium avium complex
• Mycobacterium abscessus
• Mycobacterium kansasii
• Burkholderia cepacia complex
• Bordetella pertussis
• Burkholderia pseudomallei

Tier 3 — Colonizers / Secondary Invaders

• Prevotella spp. (aspiration pneumonia)
• Serratia marcescens
• Enterobacter hormaechei
• Staphylococcus epidermidis (“Staph albus”)
• Mycoplasma hominis

Biofilm-Driven

• Staphylococcus aureus + Pseudomonas aeruginosa → CRS, bronchiectasis, antibiotic failure
• Pseudomonas aeruginosa + Burkholderia cepacia complex → Accelerated lung decline (CF)

Anaerobe–Aerobe Cooperation

• Prevotella spp. + Staphylococcus aureus → Chronic sinus inflammation
• Prevotella spp. + Enterobacter/Serratia → Aspiration pneumonia severity

Post-Viral Escalation

• Viral URI → Haemophilus influenzae ± Staphylococcus aureus → “Double worsening” pattern

Structural Lung Disease Amplifier

• Bronchiectasis/COPD → NTM ± Pseudomonas → Progressive chronic infection

 Cardiovascular (Associative)

• Prevotella intermedia
• Tannerella forsythia Periodontal–vascular inflammatory axis
• Chlamydia pneumoniae Biologic plausibility for atherosclerosis

Autoimmune / Immune Dysregulation

• Tannerella forsythia Strong RA–periodontitis association
• Chronic airway colonization (S. aureus, H. influenzae) Th17-skewed inflammation

Cancer-Adjacent Inflammation

• Mycobacterium tuberculosis Increased lung cancer risk via scarring
• Chronic airway inflammation (COPD/bronchiectasis) Inflammatory microenvironment, not direct oncogenesis

• Mycobacteria do NOT produce classic LPS endotoxin → Inflammation driven by mycolic acids & lipoarabinomannan
• Bacillus anthracis disease is toxin-mediated, not endotoxin-based

*This presentation was generated by ChatGPT for educational purposes only, with no endorsement of PhagenCorp or the Inducen formulas implied or suggested. For licensed healthcare professional use and patient education.